• Health & Medicine
• Science & Technology

Going viral: the discovery that opened the door to targeted cancer therapy

Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source. Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.

13 November 2025

• Health & Medicine
• Science & Technology

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

13 November 2025

• Health & Medicine
• Science & Technology

Skin cancer 101: what everyone should know

We’re answering some of the biggest questions about skin cancer and exploring some of the ways we're making progress for people affected by the disease. We’re answering some of the biggest questions about skin cancer and exploring some of the ways we're making progress for people affected by the disease.

12 June 2025

• Health & Medicine
• Science & Technology

Bowel cancer awareness month: Common questions answered

To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer. To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer.

1 April 2025

• Science & Technology

The DETERMINE trial: a timeline to treating the 100th patient

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

28 February 2025

• Health & Medicine
• Science & Technology

Rays of hope: how Cancer Research UK helped shape radiotherapy

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

17 February 2025

• Science & Technology
• Health & Medicine
• Policy & Insight

The story of genomics - and our plan for its next chapter

Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK. Genomics is taking us from a ‘one size fits all’ approach to cancer care to one that's much more personalised. But that change is happening quickly, and the health system is struggling to keep up. Here's our plan for making sure that genomics benefits the whole of the UK.

7 November 2024